A multimodal pharmacological agent in combination with recanalization therapy (thrombolysis and thrombectomy) in severe stroke patients
Open Access
- 1 October 2019
- journal article
- Published by S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L in Journal of Medicine and Life
- Vol. 12 (4) , 466-467
Abstract
This case report highlights a case of large ischemic stroke and indication for anticoagulant therapy treated with thrombolysis and pharmacological intervention for neurological recovery with a multimodal agent (Cerebrolysin) as add-on therapy to recanalization techniques, including IV thrombolysis. We observed a significant clinical improvement after one year of follow-up. Based on our experience, we can assert that Cerebrolysin can be safely administered in stroke patients, even in complicated cases, with a good chance for improvement of their clinical status.Keywords
This publication has 8 references indexed in Scilit:
- Efficacy and safety of cerebrolysin in neurorecovery after moderate-severe traumatic brain injury: results from the CAPTAIN II trialNeurological Sciences, 2020
- Current Drug Treatment of Acute Ischemic Stroke: Challenges and OpportunitiesCNS Drugs, 2019
- Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I—a randomized, placebo-controlled, double-blind, Asian-Pacific trialNeurological Sciences, 2019
- Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trialsNeurological Sciences, 2017
- Cerebrolysin and Recovery After Stroke (CARS)Stroke, 2016
- Effects of Cerebrolysin on the outgrowth and protection of processes of cultured brain neuronsJournal of Neural Transmission, 2001
- Antioxidant systemic effect of short-term Cerebrolysin® administration1998
- Further evidence that Cerebrolysin® protects cortical neurons from neurodegeneration in vitro1998